BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33725247)

  • 1. Phenotypic Features of Mesenchymal Stem Cell Subpopulations Obtained under the Influence of Various Toll-Like Receptors Ligands.
    Shoshina OO; Kozhin PM; Shadrin VS; Romashin DD; Rusanov AL; Luzgina NG
    Bull Exp Biol Med; 2021 Feb; 170(4):555-559. PubMed ID: 33725247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.
    Waterman RS; Tomchuck SL; Henkle SL; Betancourt AM
    PLoS One; 2010 Apr; 5(4):e10088. PubMed ID: 20436665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Umbilical Cord Mesenchymal Stem Cells: Subpopulations and Their Difference in Cell Biology and Effects on Retinal Degeneration in RCS Rats.
    Wang L; Li P; Tian Y; Li Z; Lian C; Ou Q; Jin C; Gao F; Xu JY; Wang J; Wang F; Zhang J; Zhang J; Li W; Tian H; Lu L; Xu GT
    Curr Mol Med; 2017; 17(6):421-435. PubMed ID: 29210653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors.
    van den Akker F; de Jager SC; Sluijter JP
    Mediators Inflamm; 2013; 2013():181020. PubMed ID: 24391353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization.
    Mounayar M; Kefaloyianni E; Smith B; Solhjou Z; Maarouf OH; Azzi J; Chabtini L; Fiorina P; Kraus M; Briddell R; Fodor W; Herrlich A; Abdi R
    Stem Cells; 2015 Jun; 33(6):1892-901. PubMed ID: 25753288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors.
    Mo IF; Yip KH; Chan WK; Law HK; Lau YL; Chan GC
    BMC Cell Biol; 2008 Sep; 9():52. PubMed ID: 18799018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.
    Waterman RS; Henkle SL; Betancourt AM
    PLoS One; 2012; 7(9):e45590. PubMed ID: 23029122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Human Adipose Mesenchymal Stem Cells on Phenotype Polarization of Mice Microglia via TLR3/TRIF Signal Pathway].
    Sun J; Liu YL; Li C; Ma Y; Yan WH; Su BY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 50(2):164-170. PubMed ID: 31106533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent LPS exposure commands MSC immunoplasticity through TLR4 activation leading to opposite therapeutic outcome in EAE.
    Kurte M; Vega-Letter AM; Luz-Crawford P; Djouad F; Noël D; Khoury M; Carrión F
    Stem Cell Res Ther; 2020 Sep; 11(1):416. PubMed ID: 32988406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Upregulation of Toll-Like Receptor 3 via Autocrine IFN-β Signaling Drives the Senescence of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Through JAK1.
    Lee HJ; Choi B; Kim Y; Lee SE; Jin HJ; Lee HS; Chang EJ; Kim SW
    Front Immunol; 2019; 10():1659. PubMed ID: 31396213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor-3-activated human mesenchymal stromal cells significantly prolong the survival and function of neutrophils.
    Cassatella MA; Mosna F; Micheletti A; Lisi V; Tamassia N; Cont C; Calzetti F; Pelletier M; Pizzolo G; Krampera M
    Stem Cells; 2011 Jun; 29(6):1001-11. PubMed ID: 21563279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll like receptor 3 & 4 responses of human turbinate derived mesenchymal stem cells: stimulation by double stranded RNA and lipopolysaccharide.
    Hwang SH; Cho HK; Park SH; Lee W; Lee HJ; Lee DC; Oh JH; Park SH; Kim TG; Sohn HJ; Kang JM; Kim SW
    PLoS One; 2014; 9(7):e101558. PubMed ID: 25004159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
    Liotta F; Angeli R; Cosmi L; Filì L; Manuelli C; Frosali F; Mazzinghi B; Maggi L; Pasini A; Lisi V; Santarlasci V; Consoloni L; Angelotti ML; Romagnani P; Parronchi P; Krampera M; Maggi E; Romagnani S; Annunziato F
    Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties.
    Raicevic G; Najar M; Stamatopoulos B; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Cell Immunol; 2011; 270(2):207-16. PubMed ID: 21700275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor.
    Yan H; Wu M; Yuan Y; Wang ZZ; Jiang H; Chen T
    Biochem Biophys Res Commun; 2014 May; 448(2):212-7. PubMed ID: 24780395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migration ability and Toll-like receptor expression of human mesenchymal stem cells improves significantly after three-dimensional culture.
    Zhou P; Liu Z; Li X; Zhang B; Wang X; Lan J; Shi Q; Li D; Ju X
    Biochem Biophys Res Commun; 2017 Sep; 491(2):323-328. PubMed ID: 28734835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morpho-Functional Characteristics of Bone Marrow Multipotent Mesenchymal Stromal Cells after Activation or Inhibition of Epidermal Growth Factor and Toll-Like Receptors or Treatment with DNA Intercalator Cisplatin.
    Golovynska I; Kalmukova O; Svitina HM; Kyryk VM; Shablii VA; Senchylo NV; Ostrovska GV; Dzerzhinskyi M; Stepanov YV; Golovynskyi S; Ohulchanskyy TY; Liu L; Garmanchuk LV; Qu J
    Cytometry A; 2019 Jan; 95(1):24-33. PubMed ID: 30240134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR-induced immunomodulatory cytokine expression by human gingival stem/progenitor cells.
    Mekhemar MK; Adam-Klages S; Kabelitz D; Dörfer CE; Fawzy El-Sayed KM
    Cell Immunol; 2018 Apr; 326():60-67. PubMed ID: 28093098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors and their ligands control mesenchymal stem cell functions.
    Pevsner-Fischer M; Morad V; Cohen-Sfady M; Rousso-Noori L; Zanin-Zhorov A; Cohen S; Cohen IR; Zipori D
    Blood; 2007 Feb; 109(4):1422-32. PubMed ID: 17038530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.